Streamex Corp.

Listed Company

STEXCIK 0001530766NasdaqNon-AcceleratedSmaller ReportingElectromedical & Electrotherapeutic ApparatusDelawareFY ends Dec 31

Period

FY 2025

Revenue

—

Net Income

$-462.77M

Total Assets

$187.50M

Equity

$133.19M

Shares Out

97.72M

Op. Cash Flow

$-10.40M

Business

Streamex Corp. is a medical device technology company that develops advanced digital signal processing solutions for cardiac electrophysiology procedures, marketed under the PURE EP™ Platform. It offers a combined hardware and software signal acquisition and analysis system, specialty digital filters, customizable software modules, and research algorithms for tissue characterization and pulsed field ablation guidance. The company operates through its core PURE EP business and majority‑owned subsidiaries pursuing pharmaceutical and AI applications (ViralClear and BioSig AI), and has pivoted toward software and algorithm R&D. Products and services are distributed to electrophysiology laboratories, hospitals and clinical research centers primarily through direct sales, leases and research collaborations within the U.S. clinical ecosystem.

Summary from filing dated 2025-04-15

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Revenue	—	40,000	18,000	—	—
Research and development	31,000	800,000	5	6	6
General and administrative	68	12	23	21	28
Impairment of long term assets	—	253,000	—	—	—
Depreciation and amortization	4	188,000	361,000	—	—
Total operating expenses	71	13	29	27	34
Loss from operations	−71	−13	−29	−27	−33
Interest expense, net	−2	−11,000	9,000	3,000	2,000
Change in fair value of marketable securities	−777,000	—	—	—	—
Loss on warrant settlement	−8	—	—	—	—
Change in fair value of derivative liability	−390	—	—	—	—
Change in fair value of embedded derivative	7	—	—	—	—
Gain on settlement and forgiveness of accounts payable and other liabilities	196,000	3	—	—	—
Other income (expense), net:	−33,000	23,000	−187,000	—	—
Total other income (expense), net	−393	3	—	—	—
Loss before income taxes	−464	−10	−29	−27	−33
Income taxes (benefit)	−1	—	—	—	0
Net loss	−463	−10	−29	−27	−33
Non-controlling interest	−15,000	9,000	−351,000	210,000	939,000
Net loss attributable to Streamex Corp.	−463	−10	−29	−27	−32
Preferred stock dividend	−11,000	−9,000	−9,000	−9,000	−9,000
Preferred stock deemed dividend	—	−174,000	—	−210,000	0
Net loss attributed to Streamex Corp. Common Shareholders	−463	−11	−29	−27	−32
Net loss per common share, basic	−9.65	−0.75	−3.95	−6.33	—
Net loss per common share, diluted	−9.65	−0.75	−3.95	−6.33	—
Weighted average number of common shares outstanding, basic	48	14	7	4	—
Weighted average number of common shares outstanding, diluted	48	14	7	4	—
Change in foreign currency translation adjustments	814,000	—	—	—	—
Total comprehensive loss	−462	−10	—	—	—
Comprehensive (loss) income attributable to non-controlling interest	−15,000	9,000	—	—	—
Comprehensive (loss) income attributable to Streamex Corp.	−462	−10	—	—	—

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2023 2023-01-31	FY 2022 2022-12-31
Cash	20	142,000	190,000	—	357,000
Accounts receivable	—	109,000	24,000	—	9,000
Sales tax receivable	51,000	—	—	—	—
Net investment in leases, short term	—	13,000	103,000	—	101,000
Marketable securities	10	—	—	—	—
Prepaid expenses and other assets	17	124,000	206,000	—	325,000
Total current assets	72	388,000	528,000	—	1
Property and equipment, net	25,000	85,000	509,000	—	665,000
Right-to-use assets, net	—	96,000	412,000	41,227	705,000
Net investment in leases, long term	—	4,000	17,000	—	120,000
Intangible assets, net	45	269,000	—	—	—
Goodwill	71	—	—	—	—
Total non-current assets	116	454,000	—	—	—
Total assets	188	842,000	2	—	4
Accounts payable and accrued expenses, including $66 and $19 to related parties as of December 31, 2025 and 2024, respectively.	3	2	4	—	3
Dividends payable	121,000	110,000	101,000	—	91,000
Convertible notes payable	38	—	—	—	—
Embedded derivative liability	2	—	—	—	—
Lease liability, short term	—	102,000	349,000	—	313,000
Total current liabilities	43	2	5	—	3
Deferred tax liability	11	—	—	—	—
Total liabilities	54	2	5	—	4
Commitments and contingencies (Note 10)	—	—	—	—	—
Redeemable Series C 9% Convertible Preferred Stock, $0.001 par value, $1,000 stated value, authorized 4,200 shares, 105 shares issued and outstanding; (liquidation preference of $105; cumulative dividends payable of $121 and $110 as of December 31, 2025 and 2024, respectively).	105,000	105,000	105,000	—	105,000
Preferred stock, $0.001 par value, authorized 1,000,000 shares, designated 200 shares of Series A, 600 shares of Series B, 4,200 shares of Series C, 1,400 shares of Series D, 1,000 shares of Series E, 200,000 shares of Series F Preferred Stock and 1 Special Voting Preferred Stock.	—	—	—	—	—
Common stock, $0.001 par value, authorized 500,000,000 shares, 49,805,275 and 17,239,096 issued and outstanding as of December 31, 2025 and 2024, respectively.	50,000	17,000	9,000	—	5,000
Additional paid-in-capital	850	254	242	—	216
Accumulated other comprehensive income	814,000	—	—	—	—
Accumulated deficit	−718	−255	−245	—	−216
Total stockholders equity (deficit) attributable to Streamex Corp.	133	−2	−3	—	313,000
Non-controlling interest	32,000	17,000	26,000	—	−21,000
Total stockholders equity (deficit)	133	−2	−3	—	292,000
Total liabilities and stockholders equity (deficit)	188	842,000	2	—	4

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Amortization of debt discount and issuance costs	1	—	—	—	—
Gain on settlement and forgiveness of accounts payable and other liabilities	−196,000	−3	—	—	—
Non-cash lease expense	96,000	316,000	293,000	—	—
Change in fair value of exchangeable shares derivative liability	390	—	—	—	—
Change in fair value of convertible debenture embedded derivative	−7	—	—	—	—
Fair value of liability warrants reclassified from permanent equity	8	—	—	—	—
Stock based compensation expense	57	7	8	4	10
Deferred income taxes	−1	—	—	—	—
Allowance for credit losses on accounts receivable	109,000	—	—	—	—
Accounts receivable	—	−85,000	−15,000	−9,000	0
Lease receivables	—	103,000	101,000	−220,000	0
Sales tax receivable	−36,000	—	—	—	—
Employee advances	—	5,000	−5,000	—	—
Change in net investment in leases	13,000	—	—	—	—
Prepaid expenses and other assets	−405,000	126,000	—	30,000	−50,000
Customer deposits	—	−7,000	16,000	—	—
Accounts payable and accrued expenses	597,000	571,000	1	776,000	—
Operating lease liabilities	−102,000	−350,000	−313,000	—	—
Net cash used in operating activities	−10	−5	−17	−22	−26
Purchase of investment	−144,000	—	—	—	—
Purchase of gold held as long-term investment	−24	—	—	—	—
Business acquisition, net of cash acquired	366,000	—	—	—	—
Net cash used in investing activity	−24	—	−186,000	−168,000	−542,000
Sale of common stock under at-the- market offering, net of transaction costs	17	—	—	—	—
Sale of common stock and warrants	818,000	4	—	2	1
Repayment of finance obligation	−712,000	—	—	—	—
Proceeds from convertible note payable, net of issuance costs	45	—	—	—	—
Cash paid to settle warrants	−8	—	—	—	—
Proceeds from issuance of related party note payable	—	500,000	—	—	—
Net cash provided by financing activities	55	5	17	11	10
Effect of exchange rate change on cash	−15,000	—	—	—	—
Net increase in cash	20	−48,000	—	—	—
Cash paid during the year for interest	—	—	1,000	—	0
Cash paid during the year for income taxes	—	—	—	—	—
Recognition of derivative liability as part of business combination	105	—	—	—	—
Recognition of assets acquired as part of business combination	118	—	—	—	—
Recognition of liabilities assumed as part of business combination	13	—	—	—	—
Common stock issued in settlement of accounts payable and accrued expenses	683,000	122,000	—	—	—
Dividend payable on preferred stock charged to additional paid-in-capital	11,000	9,000	9,000	—	—
Financing obligation entered into in exchange for prepaid insurance	2	—	—	—	—
Prepaid stock based compensation	15	—	—	—	—
Investment in Empress Royalty Corp. acquired through issuance of common stock	10	—	—	—	—
Common stock issued in settlement of accrued severance	—	45,000	—	—	—
Series C convertible preferred stock deemed dividend	—	174,000	—	210,000	—
Common stock issued for conversion of note payable and accrued interest	—	509,000	—	—	—

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro